Benzinga | May 5, 2021 04:32PM EDT

Neurocrine Biosciences Q1 Adj. EPS $0.49 Misses $0.51 Estimate, Sales $236.60M Miss $250.63M Estimate

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.49 per share which missed the analyst consensus estimate of $0.51 by 3.92 percent. This is a 40.24 percent decrease over earnings of $0.82 per share from the same period last year. The company reported quarterly sales of $236.60 million which missed the analyst consensus estimate of $250.63 million by 5.60 percent. This is a 0.21 percent decrease over sales of $237.10 million the same period last year.